Patents by Inventor Jonathan Scheiman

Jonathan Scheiman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230302063
    Abstract: A probiotic formulation is provided including one or more bacteria, bacterial strains or bacterial species of the genus Veillonella, genus Faecalibacterium, genus Phascolarctobacteria, genus Oscillospira, genus Ruminococcus, genus Bacteroides, genus Blautia, family Christensenellaceae, genus Dialister, or phylum cyanobacteria.
    Type: Application
    Filed: April 25, 2023
    Publication date: September 28, 2023
    Inventors: Jonathan Scheiman, George M. Church
  • Patent number: 11666610
    Abstract: A probiotic formulation is provided including one or more bacteria, bacterial strains or bacterial species of the genus Veillonella, genus Faecalibacterium, genus Phascolarctobacteria, genus Oscillospira, genus Ruminococcus, genus Bacteroides, genus Blautia, family Christensenellaceae, genus Dialister, or phylum cyanobacteria.
    Type: Grant
    Filed: April 18, 2022
    Date of Patent: June 6, 2023
    Assignee: President and Fellows of Harvard College
    Inventors: Jonathan Scheiman, George M. Church
  • Publication number: 20230112367
    Abstract: The disclosure provides novel microorganisms, such as Lactobacillus sp., Bifidobacterium sp., and Veillonella sp., and compositions thereof for improving athletic performance, enhancing exercise endurance, improving physical recovery from exercise, and reducing inflammation in a subject in need thereof.
    Type: Application
    Filed: March 15, 2021
    Publication date: April 13, 2023
    Inventor: Jonathan SCHEIMAN
  • Publication number: 20220403324
    Abstract: The disclosure provides novel microbial strains, such as Veillonella sp. strains, and compositions comprising the strains that are capable of converting lactate to propionate and acetate. The disclosure also provides compositions comprising the Veillonella sp. strains and lactate producing bacteria, such as Lactobacillus sp. strains and Bifidobacterium sp. strains. The disclosure further provides methods of improving athletic performance, enhancing exercise endurance and reducing inflammation in a subject upon administration of the disclosed strains or compositions.
    Type: Application
    Filed: November 25, 2020
    Publication date: December 22, 2022
    Inventor: Jonathan SCHEIMAN
  • Publication number: 20220241351
    Abstract: A probiotic formulation is provided including one or more bacteria, bacterial strains or bacterial species of the genus Veillonella, genus Faecalibacterium, genus Phascolarctobacteria, genus Oscillospira, genus Ruminococcus, genus Bacteroides, genus Blautia, family Christensenellaceae, genus Dialister, or phylum cyanobacteria.
    Type: Application
    Filed: April 18, 2022
    Publication date: August 4, 2022
    Inventors: Jonathan Scheiman, George M. Church
  • Patent number: 11324783
    Abstract: A probiotic formulation is provided including one or more bacteria, bacterial strains or bacterial species of the genus Veillonella, genus Faecalibacterium, genus Phascolarctobacteria, genus Oscillospira, genus Ruminococcus, genus Bacteroides, genus Blautia, family Christensenellaceae, genus Dialister, or phylum cyanobacteria.
    Type: Grant
    Filed: August 6, 2021
    Date of Patent: May 10, 2022
    Assignee: President and Fellows of Harvard College
    Inventors: Jonathan Scheiman, George M. Church
  • Publication number: 20220054559
    Abstract: The technology described herein is directed to compositions and methods for enhancing exercise endurance. In some embodiments of any of the aspects, a composition comprises a Veillonella probiotic bacteria. In some embodiments of any of the aspects, Veillonella probiotic bacteria and or propionate is administered to a patient in need thereof. In some embodiments of any of the aspects, a composition comprises a probiotic bacteria engineered to express genes encoding enzymes sufficient to metabolize the conversion of lactate into short-chain fatty acids comprising one or more of propionate and acetate.
    Type: Application
    Filed: February 21, 2020
    Publication date: February 24, 2022
    Applicants: PRESIDENT AND FELLOWS OF HARVARD COLLEGE, JOSLIN DIABETES CENTER, INC.
    Inventors: Jonathan SCHEIMAN, George M. CHURCH, Aleksandar D. KOSTIC, Theodore Andrew CHAVKIN, Jacob Mayne LUBER
  • Publication number: 20210369794
    Abstract: A probiotic formulation is provided including one or more bacteria, bacterial strains or bacterial species of the genus Veillonella, genus Faecalibacterium, genus Phascolarctobacteria, genus Oscillospira, genus Ruminococcus, genus Bacteroides, genus Blautia, family Christensenellaceae, genus Dialister, or phylum cyanobacteria.
    Type: Application
    Filed: August 6, 2021
    Publication date: December 2, 2021
    Inventors: Jonathan Scheiman, George M. Church
  • Patent number: 11090342
    Abstract: A probiotic formulation is provided including one or more bacteria, bacterial strains or bacterial species of the genus Veillonella, genus Faecalibacterium, genus Phascolarctobacteria, genus Oscillospira, genus Ruminococcus, genus Bacteroides, genus Blautia, family Christensenellaceae, genus Dialister, or phylum cyanobacteria.
    Type: Grant
    Filed: April 10, 2017
    Date of Patent: August 17, 2021
    Assignee: President and Fellows of Harvard College
    Inventors: Jonathan Scheiman, George M. Church
  • Patent number: 10526649
    Abstract: The invention provides in situ nucleic acid sequencing to be conducted in biological specimens that have been physically expanded. The invention leverages the techniques for expansion microscopy (ExM) to provide new methods for in situ sequencing of nucleic acids in a process referred to herein as “expansion sequencing” (ExSEQ).
    Type: Grant
    Filed: October 20, 2017
    Date of Patent: January 7, 2020
    Assignees: Massachusetts Institute of Technology, President and Fellows of Harvard College
    Inventors: Fei Chen, Shahar Alon, Andrew Payne, Asmamaw Wassie, Daniel Goodwin, Edward Stuart Boyden, Evan Daugharthy, Jonathan Scheiman
  • Publication number: 20190160118
    Abstract: A probiotic formulation is provided including one or more bacteria, bacterial strains or bacterial species of the genus Veillonella, genus Faecalibacterium, genus Phascolarctobacteria, genus Oscillospira, genus Ruminococcus, genus Bacteroides, genus Blautia, family Christensenellaceae, genus Dialister, or phylum cyanobacteria.
    Type: Application
    Filed: April 10, 2017
    Publication date: May 30, 2019
    Inventors: Jonathan Scheiman, George M. Church